Predicting seizure freedom after epilepsy surgery, a challenge in clinical practice.


Journal

Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858

Informations de publication

Date de publication:
06 2019
Historique:
received: 24 01 2019
revised: 08 03 2019
accepted: 27 03 2019
pubmed: 30 4 2019
medline: 7 7 2020
entrez: 30 4 2019
Statut: ppublish

Résumé

The objective of this study was to compare the accuracy of clinical judgment in predicting seizure outcome after resective epilepsy surgery relative to two recently published statistical tools [the Epilepsy Surgery Nomogram (ESN) and the modified Seizure-Freedom score (m-SFS)]. Details of presurgical evaluations of 20 patients who underwent epilepsy surgery were presented to 20 epilepsy experts. The final surgical treatment was also disclosed. The clinicians were asked to predict the likelihood of a good outcome (Engel 1) at 2 and 5 years in each case. The ESN and the m-SFS predictions were calculated with the data provided to the clinicians. The discriminative ability of clinical judgment, ESN, and m-SFS was assessed by calculating a concordance index (C-index). Expert opinion, the m-SFS and the ESN performances were compared using a Receiver Operating Characteristic (ROC) curve analysis. The mean age at surgery was 29 years (standard deviation [SD] = 14); 40% were male; 70% were right-handed, and thirteen (65%) had an Engel outcome 1 at 2 and 5 years. The mean C-index for the mean physician's prediction was 0.478 with a variance of 0.012. The ESN had an area under the curve (AUC) of 0.528 and 0.533 for the 2-year and 5-year predictions in comparison with the clinicians' predictions that was 0.476, and 0.466, respectively. For the m-SFS, the AUC at 2 years and 5 years was 0.539 and 0.539, respectively. No statistical difference was noted between the ESN and the clinicians or between m-SFS and the ESN, but there is a moderate statistical difference favoring the m-SFS to the clinicians (p 0.0960 and 0.0514, for 2 and 5 years). Clinical judgment was not superior to the ESN nor to the m-SFS. Together with the interphysician's prediction variability, our findings reinforce the need for better tools to predict postoperative outcomes.

Identifiants

pubmed: 31035104
pii: S1525-5050(19)30077-0
doi: 10.1016/j.yebeh.2019.03.047
pmc: PMC6546523
mid: NIHMS1526383
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

124-130

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS097719
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Methods Inf Med. 2001 Mar;40(1):1-5
pubmed: 11310153
N Engl J Med. 2001 Aug 2;345(5):311-8
pubmed: 11484687
Brain. 2004 Sep;127(Pt 9):2018-30
pubmed: 15215219
Epilepsy Res. 2004 Nov;62(1):75-87
pubmed: 15519134
Int J Med Inform. 2008 Feb;77(2):81-97
pubmed: 17188928
Brain. 2007 Feb;130(Pt 2):574-84
pubmed: 17209228
Epilepsia. 2008 Aug;49(8):1317-23
pubmed: 18557776
Seizure. 2012 Sep;21(7):546-9
pubmed: 22717516
Seizure. 2012 Nov;21(9):722-8
pubmed: 22902290
Epilepsia. 2012 Oct;53(10):1731-8
pubmed: 22958128
Urology. 2013 May;81(5):956-61
pubmed: 23375915
Epilepsia. 2013 May;54(5):772-82
pubmed: 23586531
N Engl J Med. 2013 Jun 27;368(26):2445-8
pubmed: 23802513
BMJ Qual Saf. 2013 Oct;22 Suppl 2:ii58-ii64
pubmed: 23882089
BMJ Qual Saf. 2013 Oct;22 Suppl 2:ii65-ii72
pubmed: 23996094
Seizure. 2014 Jun;23(6):448-53
pubmed: 24680551
Epilepsia. 2015 Mar;56(3):359-65
pubmed: 25530458
Lancet Neurol. 2015 Mar;14(3):283-90
pubmed: 25638640
Clin Med (Lond). 2016 Aug;16(4):343-6
pubmed: 27481378
BMC Med Inform Decis Mak. 2016 Nov 3;16(1):138
pubmed: 27809908

Auteurs

Camilo Garcia Gracia (CG)

Cleveland Clinic Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, United States of America.

Kevin Chagin (K)

Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH 44195, United States of America.

Michael W Kattan (MW)

Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH 44195, United States of America.

Xinge Ji (X)

Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH 44195, United States of America.

Madeleine G Kattan (MG)

Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH 44195, United States of America.

Lizzie Crotty (L)

Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH 44195, United States of America.

Imad Najm (I)

Cleveland Clinic Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, United States of America.

Jorge Gonzalez-Martinez (J)

Cleveland Clinic Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, United States of America.

William Bingaman (W)

Cleveland Clinic Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, United States of America.

Lara Jehi (L)

Cleveland Clinic Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, United States of America. Electronic address: jehil@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH